Combinostics raises €3.9M to support early Alzheimer’s diagnosis by healthcare professionals
Series A round lead investors NordicNinja and Industrifonden to support Combinostics as they scale to US and Asia HELSINKI, Finland (November 21st, 2019) Finnish health tech pioneer Combinostics has announced the closure of a...
Nihon Medi-Physics and Combinostics Enter into an Exclusive Agreement to Develop and Market Software to Support Diagnosing Dementia
Tokyo Japan and Tampere, Finland July 3, 2019, Nihon Medi-Physics Co., Ltd. (NMP) and Combinostics Oy (Combinostics) today announced the signing of an exclusive agreement to develop and market cloud-based dementia diagnosis support software (the Software) in Japan....
Three new journal papers published
Three journal papers relevant to cNeuro have been published in early 2019. Visual rating scales are commonly used in assessing MRI images of patients with cognitive disorders, especially in Europe. The paper in European Radiology shows that such rating scales can be...
Meet Combinostics at ECR in Vienna
Combinostics will be attending the ECR conference in Vienna 27 February – 3 March. We will showcase our cNeuro® cMRI application for quantitative analysis of MRI scans, and our cNeuro® cDSI application for clinical decision support in dementia. You will find us in the...
Combinostics selected for the MassChallenge HealthTech’s 2019 Cohort of Top Digital Health Companies
Combinostics today announced that the company has been selected for the MassChallenge HealthTech 2019 program in Boston. MassChallenge is a global network of zero-equity startup accelerators. Combinostics was selected for the Boston program by a pool of institutions,...